First patient enrolled in Phase 3 trial of mocertatug rezetecan for platinum-resistant ovarian cancer
Philadelphia, PA, USA — July 27, 2026 — The GOG Foundation, Inc. announced the enrollment of the first patient in ...
Philadelphia, PA, USA — July 27, 2026 — The GOG Foundation, Inc. announced the enrollment of the first patient in ...
In a groundbreaking stride against one of oncology's most formidable challenges, researchers have unveiled promising clinical trial results exploring novel ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine